Eris Lifesciences Limited IPO Message Board (Page 13)

Allotment not before 24th evening ......?

GMP for Eris pls....egarly waiting for listing..my view is 25-30

I have withdrawn my bid as don''t want to take the risk.

How to withdraw ipo bid applied from SBI.

Very good... your money will be very safe...

If issue is undersubscibed, it will be next Sheela form. If issue is overwhelming subscribed, it will behave like nhpc, Rpower.

Really these days, forum members posts any nonsense logic for listing.

Doubt if Eris will list more than 10 Rs to the cut off

So What is your doubt. definitely it will list more than 10 Rs to the cut off price

@ 333. Nitali
Doubt if Eris will list more than 10 Rs to the cut off

^^ Aw.... I am not going to ask you WHY ..All I want to say is, for such cute cute intuition, you deserve a chocolate :D

eris ki listing kitne per hogi ? I talk with their board of members , they told me that this will be listing 25 % premium , So all are requested to please enjoy the listing

Why employees portion is not fully subscribed even there was 60 rupees discount per share??
Two reasons
1. Employees are not confident company performance
2. Company share will open in discount more then 60 rupees.

Don''t think that the employees are any smart. After all they are employees, not owners. In most cases they have no more information than any one in public has.

The ones who have all the info will either apply in full, or already have esops or not applying. In all the three cases we can never know.

because not everyone has 15000 in spare to apply!!!

DEAR EAGLEEYE

YOUR VIEWS ON LISTING PRICE OF ERIS.
WHAT ARE THE CHANCES OF LISTING AT A PREMIUM.
PLEASE ALSO CONFIRM IF YOU HAVE APPLIED FOR ERIS.

Eris LifeSciences IPO
No Trades

DEAR EAGLEYE
WELCOME BACK TO THE FORUM.
CAN YOU PLEASE CONFIRM LATEST GMP AND LIKELY LISTNG PRICE OF ERIS.
I HAVE APPLIED FOR 6 LOTS.

Yes. People invested in CDSL. Now Hathway will face the music.

Subscription not up to the expectation....to this ipo.

agree......see CDSL and then compare with TEJAS and ERIS.

This is only because of CDSL IPO came together. People invested in CDSL instead of Eris

Eris LifeSciences IPO – Schedule – Page #290 of RHP
15th June – Anchor List
16h June – Offer Opens
20th June – Offer Closes
23st June – Finalisation of Basis of Allotment
27th June – Unblocking of ASBA
28th June – Credit to Demat Accounts
29th June – Listing on NSE & BSE

The IPO was expensive but will surprise with listing. The best part is it is debt free company, most companies pay off their debts through proceeds.

People are focussing more on CDSL rather than Eris. it was better to invest in CDSL but the chances of allotment in CDSL are very less because of huge oversubscription.

People who invested in Eris will get allotment(Chances are very high) and it will list above the issue price but not as good as CDSL.
So not to worry about the listing price.

Allotment will be out day after tomorrow .....on 24th ...quite fast ...!

Coz applications are less 😎

Almost everyone is alloted

Eris is debr free company with good potential...so one can surely hold for longer term.

The way this forum is split, there is huge learning going to happen when the scrip lists for both who applied and who didn''t. I can also see this listing being cited as example in a lot of future listings as well.

CDSL subscription speaks for itself. Here we have everyday one person coming and supporting this IPO and people who have applied giving it thumbs up. We will see this trend continue till listing next week, because people are more tensed after seeing blockbuster CDSL subscription

GLIMISAVE M 1 TABLET - Flagship product of Eris Life sciences

just discussed with few industry insiders about this products, may be this can help to evaluate growth of this company.
Product is available is at most competitive prices than peers. (abott, sun pharma)
marketing is based on direct cut (those who are familiar with pharma marketing knows what i mean), which is best as consumer do not directly buy any medicine.

I could not connect with MR''s dealing with gastro & neuro division, but in diabetes segment they are soon gonna lead.

This is information I am sharing, nothing to take with how stock will perfom in short term